Dow Down 0.24% Nasdaq Up 0.25%

Albany Molecular Research Inc. (AMRI)

-NasdaqGS
19.10 Down 0.70(3.54%) 3:27PM EDT - Nasdaq Real Time Price
Prev Close:19.80
Open:19.94
Bid:19.07 x 200
Ask:19.11 x 500
1y Target Est:18.75
Beta:2.09
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:19.06 - 19.94
52wk Range:9.71 - 22.30
Volume:415,465
Avg Vol (3m):408,989
Market Cap:602.72M
P/E (ttm):63.04
EPS (ttm):0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AMRI

Comparison

Symbol% ChgMkt Cap
AMRIDown 3.54%602.72M
CVDUp 0.36%4.70B
QDown 0.39%7.11B

Key Statistics

Forward P/E (1 yr):16.62
P/S (ttm):2.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.91
Quarterly EPS Est (Sep-14) :0.17
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback